MMP9 and myeloid sarcoma: Carrai et al.2 compared bone marrow from patients with non-Hodgkin’s lymphoma and MS andreported reduced cellularity in MS with a trend towards increased fibrosis andreduced matrix metallopeptidase-9 (MMP-9) expression.